India is among the top 12 global destinations and 3rd in the Asia-Pacific region in Biotechnology R&D.
FDI through automatic route for new projects.
producer of recombinant Hepatitis B vaccine.
highest number of USFDA-approved plants outside the US.
producer of BT cotton variety in the world.
projected value of biotech sector by 2025 with 30.5% CAGR.
destination for clinical trials, contract research, and manufacturing.
USFDA approved pharma plants in India; 2nd largest outside of USA.
biotechnology companies in India, driving global partnerships.
bio-incubators and 9 biotech parks, with new ones in the pipeline.
Recognizing the need for regulation of the use and application of Deoxyribonucleic Acid (DNA) technology in the country, “The DNA Technology (Use and Application) Regulation Bill - 2019”, has been formulated for establishing identity of missing persons, victims, offenders, under trials and unknown deceased persons.
+91-11-26511439, 26510068, 23386051
India has a well-oiled enterprise promoting machinery that is backed by strong legislative, judiciary, executive and capital establishments
Abbot Laboratories - American health care company
Sanofi Aventis - providers of diabetes drugs and vaccines
Endo Pharmaceuticals - Generics and speciality manufacturer
GE Healthcare - Medical equipment & diagnostic products
Bosch - Healthcare and medical technology manufacturer
Helix - Planning and design of healthcare facilities
BPI - IT solutions for business requirements in life sciences
Tekes - Financing research, development and innovation
India has a well-oiled enterprise promoting machinery that is backed by strong legislative, judiciary, executive, and capital establishments